Structures by: Orola L.
Total: 25
4-aminosalicylic acid - nicotinamide cocrystal
C7H7NO3,C6H6N2O
New Journal of Chemistry (2013) 37, 10 2978
a=4.58580(10)Å b=12.6009(2)Å c=21.2600(4)Å
α=90.00° β=94.0440(7)° γ=90.00°
Nicotinamide fumaric acid 1:1
C10H10N2O5
CrystEngComm (2009) 11, 3 415
a=5.550(1)Å b=13.792(1)Å c=14.360(2)Å
α=90° β=93.41(1)° γ=90°
Nicotinamide fumaric acid 2:1
C16H16N4O6
CrystEngComm (2009) 11, 3 415
a=5.592(3)Å b=12.044(1)Å c=13.131(5)Å
α=90° β=96.00(5)° γ=90°
Isoniazid-adipic acid cocrystal II
C6H10O4,2(C6H7N3O)
CrystEngComm (2016) 18, 9 1625
a=16.200(10)Å b=7.378(7)Å c=8.793(6)Å
α=90.000° β=105.079(30)° γ=90.000°
C32H24N2O3
C32H24N2O3
CrystEngComm (2012) 14, 21 7253
a=9.450(2)Å b=11.830(2)Å c=11.964(2)Å
α=114.83(3)° β=101.03(3)° γ=94.64(3)°
C18H14N2O3
C18H14N2O3
CrystEngComm (2012) 14, 21 7253
a=7.3010(15)Å b=16.518(3)Å c=24.294(3)Å
α=90° β=98.53(3)° γ=90°
C18H14N2O3
C18H14N2O3
CrystEngComm (2012) 14, 21 7253
a=10.6419(3)Å b=12.6654(4)Å c=22.1187(6)Å
α=90° β=90° γ=90°
Xylazine hydrochloride monohydrate
C12H17N2S,Cl,H2O
Acta Crystallographica Section E (2008) 64, 6 o1062
a=13.4546(2)Å b=8.65470(10)Å c=12.7732(2)Å
α=90.0° β=109.210(2)° γ=90.0°
Sygethin dihydrate
2(K),C18H20O6S22,2(H2O)
Acta Crystallographica Section E (2008) 64, 8 m1027
a=5.8741(5)Å b=6.5684(5)Å c=15.2335(14)Å
α=84.272(4)° β=83.768(5)° γ=76.522(6)°
Cinnamic acid--isoniazid (1/1)
C6H7N3O,C9H8O2
Acta Crystallographica Section C (2014) 70, 4 392-395
a=6.4872(2)Å b=8.1478(4)Å c=13.56030(11)Å
α=95.1691(11)° β=101.1111(11)° γ=98.6376(17)°
Cinnamic acid--<i>N</i>'-(propan-2-ylidene)isonicotinohydrazide (1/1)
C9H11N3O,C9H8O2
Acta Crystallographica Section C (2014) 70, 4 392-395
a=8.88180(10)Å b=21.0445(4)Å c=9.07640(10)Å
α=90.00° β=90.00° γ=90.00°
N,N'-diphenylbenzamidinium fumarate
2(C19H17N2),C4H2O4
Acta Crystallographica Section E (2010) 66, 7 o1597
a=10.5972(3)Å b=8.8275(3)Å c=18.7710(7)Å
α=90° β=102.3460(10)° γ=90°
Phenanthridine isophthalic acid 1:1
C13H9N,C8H6O4
Crystal Growth & Design (2011) 11, 9 4009
a=11.915(2)Å b=3.8719(8)Å c=17.285(4)Å
α=90° β=91.79(3)° γ=90°
Phenanthridine succinic acid 2:1
C13H9N,0.5(C4H6O4)
Crystal Growth & Design (2011) 11, 9 4009
a=4.901(1)Å b=17.210(3)Å c=13.989(3)Å
α=90° β=90.90(3)° γ=90°
Phenanthridine fumaric acid 4:1.5
4(C13H9N),1.5(C4H4O4)
Crystal Growth & Design (2011) 11, 9 4009
a=11.299(2)Å b=13.591(3)Å c=15.293(3)Å
α=78.55(3)° β=75.83(3)° γ=75.89(3)°
Phenanthridine fumaric acid 2:1
C13H9N,0.5(C4H4O4)
Crystal Growth & Design (2011) 11, 9 4009
a=3.900(1)Å b=20.070(4)Å c=14.489(3)Å
α=90° β=97.58(3)° γ=90°
Phenanthridinium maleate
C13H10N,C4H3O4
Crystal Growth & Design (2011) 11, 9 4009
a=5.712(1)Å b=8.131(2)Å c=14.943(3)Å
α=90° β=93.42(3)° γ=90°
Phenanthridinium oxalate
C13H10N,C2HO4
Crystal Growth & Design (2011) 11, 9 4009
a=5.584(1)Å b=10.230(2)Å c=10.962(2)Å
α=75.17(3)° β=84.53(3)° γ=86.35(3)°
Phenanthridinium oxalate monohydrate
C13H10N,C2HO4,H2O
Crystal Growth & Design (2011) 11, 9 4009
a=7.557(2)Å b=9.469(2)Å c=18.562(4)Å
α=90° β=95.51(3)° γ=90°
Isoniazid - benzoic acid cocrystal
C6H7N3O,C7H6O2
Crystal Growth & Design (2013) 13, 3 1082
a=25.8154(12)Å b=3.8880(6)Å c=6.1323(6)Å
α=90.00° β=88.416(4)° γ=90.00°
Izoniazid - suberic acid cocrystal
C8H14O4,2(C6H7N3O)
Crystal Growth & Design (2013) 13, 3 1082
a=6.8989(2)Å b=7.4686(3)Å c=21.3750(9)Å
α=84.0960(10)° β=82.3810(10)° γ=89.843(2)°
Isoniazid - cinnamic acid cocrystal
C9H8O2,C6H7N3O
Crystal Growth & Design (2013) 13, 3 1082
a=7.4573(3)Å b=9.5154(4)Å c=10.1737(3)Å
α=96.904(3)° β=103.264(2)° γ=101.9457(18)°
Isoniazid - cinnamic cocrystal II
C9H8O2,C6H7N3O
Crystal Growth & Design (2013) 13, 3 1082
a=14.9124(8)Å b=3.7468(2)Å c=24.3089(16)Å
α=90.00° β=96.975(2)° γ=90.00°
Isoniazid - sebacic acid cocrystal
C10H18O4,2(C6H7N3O)
Crystal Growth & Design (2013) 13, 3 1082
a=6.8942(6)Å b=7.1004(6)Å c=12.4475(12)Å
α=104.455(4)° β=92.400(3)° γ=95.106(4)°
C63H60N9O12
C63H60N9O12
CrystEngComm (2012) 14, 21 7253
a=14.931(3)Å b=15.372(3)Å c=15.647(3)Å
α=60.72(3)° β=67.16(3)° γ=67.07(3)°